Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 21, 2007; 13(11): 1652-1658
Published online Mar 21, 2007. doi: 10.3748/wjg.v13.i11.1652
Published online Mar 21, 2007. doi: 10.3748/wjg.v13.i11.1652
HepG2 (%) | BEL7402 (%) | L-02 (%) | ||||
UDCA (mmol/L) | bcl-2 | Bax | bcl-2 | Bax | bcl-2 | Bax |
0 (control) | 24.3 ± 2.4 | 43.0 ± 5.0 | 21.6 ± 1.8 | 44.0 ± 4.0 | 1.0 ± 0.2 | 62.0 ± 4.0 |
0.2 | 19.4 ± 1.5c | 42.0 ± 4.0a | 20.1 ± 1.9a | 48.4 ± 2.5a | 1.0 ± 0.1a | 61.0 ± 5.0a |
0.4 | 14.2 ± 2.1b | 53.6 ± 2.5c | 13.5 ± 1.8b | 56.0 ± 4.0c | 0.8 ± 0.1a | 59.0 ± 3.0a |
0.8 | 10.1 ± 1.6b | 59.0 ± 3.0b | 11.6 ± 2.1b | 59.0 ± 3.0b | 0.6 ± 0.3a | 64.0 ± 4.0a |
- Citation: Liu H, Qin CY, Han GQ, Xu HW, Meng M, Yang Z. Mechanism of apoptotic effects induced selectively by ursodeoxycholic acid on human hepatoma cell lines. World J Gastroenterol 2007; 13(11): 1652-1658
- URL: https://www.wjgnet.com/1007-9327/full/v13/i11/1652.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i11.1652